Last €6.98 EUR
Change Today 0.00 / 0.00%
Volume 0.0
WM4 On Other Exchanges
EN Paris
EN Paris
EN Paris
As of 4:00 PM 11/14/14 All times are local (Market data is delayed by at least 15 minutes).

sequana (WM4) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SEQUANA (WM4)

Related News

No related news articles were found.

sequana (WM4) Related Businessweek News

No Related Businessweek News Found

sequana (WM4) Details

Sequana S.A. produces and distributes papers worldwide. It is also involved in the B2B distribution of paper and packaging products. The company distributes coated and non-coated papers, creative papers, envelopes, specialty papers, and graphic supplies, as well as a range of ad hoc services and solutions; various reams for photocopiers or printers; packaging products, such as kraft papers, bubble wraps, cardboard boxes, and strapping and packaging machines to protect goods during transportation and storage; and cardboards, plastics, and papers for posters, point of sale advertising, signage, store and car window displays, and banners. It also produces graphic and specialty papers, including coated and uncoated paper, and recycled paper for publishing and printed communication; recycled pulp; specialty papers, such as playing cards, transfer papers, and tissues; and Forest Stewardship Council certified papers. In addition, the company offers papers for business stationery, corporate communication, advertising and promotion, packaging, and bookbinding; tracing paper for technical drawings; casting paper for the fashion, leather, and car industries; paper for banknotes, cheque books, vouchers, etc; paper for proof-of-identity documentation; and water-resistant and synthetic papers. Further, it provides sterile packaging for the protection of disposable medical instruments; sterilized sealing and wrapping solutions to protect reusable medical equipments for use in operating theatres; and brand protection solutions. The company primarily serves printers and publishers; companies and government agencies; professionals specialized in signage systems; industrial firms; graphic designers; editors; advertising agencies; medical and hospital sectors; resellers; and small, medium, and large businesses. Sequana S.A. is headquartered in Boulogne-Billancourt, France.

10,000 Employees
Last Reported Date: 04/30/14

sequana (WM4) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: €900.0K
Compensation as of Fiscal Year 2013.

sequana (WM4) Key Developments

Sequana Reports Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Sequana reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported sales of EUR 817 million against EUR 779 million a year ago. EBITDA was EUR 20 million against EUR 25 million a year ago. Recurring operating income was EUR 8 million against EUR 7 million a year ago. Net income attributable to owners was EUR 216 million against net loss attributable to owners of EUR 21 million a year ago. For the nine months, the company reported sales of EUR 2,537 million against EUR 2,453 million a year ago. EBITDA was EUR 88 million against EUR 87 million a year ago. Recurring operating income was EUR 50 million against EUR 31 million a year ago. Net income attributable to owners was EUR 136 million or EUR 2.18 per diluted share against net loss attributable to owners of EUR 58 million or EUR 1.87 per diluted share a year ago.

Sequana S.A. Reports Consolidated Earnings Results for the First Half of 2014

Sequana S.A. reported consolidated earnings results for the first half of 2014. For the period, the company reported sales of EUR 1,720 million against EUR 1,674 million a year ago. Recurring operating income was EUR 42 million against EUR 24 million a year ago. Operating loss was EUR 35 million against operating income of EUR 3 million a year ago. Net financial loss was EUR 29 million against EUR 27 million a year ago. Net loss attributable to the company shareholders was EUR 80 million against EUR 36 million a year ago. Basic and diluted loss per share from continuing operations was EUR 2.93 against EUR 1.28 a year ago. Basic and diluted consolidated loss per share was EUR 3.20 against EUR 1.46 a year ago. Net cash used in operating activities was EUR 182 million against EUR 44 million a year ago. Expenditure on acquisitions of property, plant and equipment and intangible were EUR 20 million against EUR 21 million a year ago. EBITDA was EUR 68 million against EUR 62 million a year ago.

Sequana S.A. to Report Q3, 2014 Sales/Trading Statement Results on Oct 24, 2014

Sequana S.A. announced that they will report Q3, 2014 sales/trading statement results on Oct 24, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WM4:GR €6.98 EUR 0.00

WM4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
INAPA - Investimentos Participacoes e Gestao SA €0.18 EUR -0.002
PaperlinX Ltd A$0.02 AUD +0.001
Resolute Forest Products Inc $17.51 USD -0.40
UPM-Kymmene OYJ €17.21 EUR +0.41
Verso Corp $2.22 USD -0.02
View Industry Companies

Industry Analysis


Industry Average

Valuation WM4 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book 0.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUANA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at